Trial Profile
Open-label, multicenter study to assess the efficacy, safety, tolerability, and pharmacokinetics of bosentan in Japanese children with pulmonary arterial hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 31 May 2016 New trial record